Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Iu A, Kucheriavyĭ"'
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 4-10 (2015)
The paper analyzes an evidence base for the pharmacotherapy of irritable bowel syndrome (IBS) A large number of randomized placebo-controlled trials (RPCTs) systematized in a number of meta-analyses suggest that monotherapy regimens with spasmolytics
Externí odkaz:
https://doaj.org/article/0bcfcb5df7d9401481dfda99ef076965
Publikováno v:
Терапевтический архив, Vol 86, Iss 3, Pp 94-99 (2014)
The literature review gives current views on the treatment of Helicobacter pylori infection. The rising antibiotic resistance of H. pylori in the first decade of the 21st century entailed the decreased efficiency of common eradication therapy (ET) re
Externí odkaz:
https://doaj.org/article/d6f5c1020bb54c13b06c0e34530da44d
Publikováno v:
Терапевтический архив, Vol 86, Iss 2, Pp 82-89 (2014)
The paper gives the current views of the diagnosis and treatment of Zollinger-Ellison syndrome (ZES). It underlines the importance of including ZES in differential diagnosis in patient with frequently recurrent and standard-dose proton pump inhibitor
Externí odkaz:
https://doaj.org/article/b43888e7b7854991acb54468b5019831
Publikováno v:
Терапевтический архив, Vol 85, Iss 4, Pp 84-89 (2013)
The paper gives practical recommendations based on the provisions of a number of foreign national guidelines for the diagnosis of chronic pancreatitis (CP). There is virtually no evidence for Class I database for its diagnosis. Despite an inadequate
Externí odkaz:
https://doaj.org/article/52b143b03bc04866a6fb13c13d693bf6
Publikováno v:
Терапевтический архив, Vol 85, Iss 2, Pp 65-72 (2013)
The paper deals with the difficulties and errors that are most commonly used in clinical practice to manage patients with chronic pancreatitis (CP). The higher interest in CP is inspired by the wide prevalence of this disease with its constant upward
Externí odkaz:
https://doaj.org/article/f5fece9826084d789c79b2e5d5c3686d
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 4-10 (2015)
The paper analyzes an evidence base for the pharmacotherapy of irritable bowel syndrome (IBS) A large number of randomized placebo-controlled trials (RPCTs) systematized in a number of meta-analyses suggest that monotherapy regimens with spasmolytics
Publikováno v:
Klinicheskaia meditsina. 92(11)
Sarcoidosis is a multisystemic disease of unknown etiology characterized by formation of non-caseificating epithelioid cell granulomas in affected organs. The clinically manifest involvement of the gastrointestinal tract (GIT) in the pathological pro
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (4)
In different countries a set of recommendations for the diagnostics and treatment of chronic pancreatitis (CP) have been published, but to date a unified systematic management has not been developed yet. Because CP is within the interests of physicia
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (10)
For the first time the relationship between mutations in the pancreatic secretory trypsin inhibitor (SPINK1) in humans and the development of chronic pancreatitis was established in 2000. By mid 2011 the number of studies on the influence of SPINK1 g
Autor:
Iu A, Kucheriavyĭ, N V, Petrova, Z F, Tibilova, A V, Smirnov, T S, Oganesian, A N, Kaziulin, I V, Maev
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (7)
To determine the frequency and prognostic significance of mutation N34S in the development of CP in a mixed Russian population.The study included 83 patients with idiopathic CP and 103 healthy individuals. The diagnosis of CP was based on clinical an